Jeroen F. Prette
Papers
1
Total Citations
20
H-Index
1
About
Jeroen F. Prette is a leading figure in oncological imaging, with a primary focus on advancing the diagnosis and staging of prostate cancer through cutting-edge hybrid imaging techniques. His most influential work centers on the comparative performance of novel radiotracers and multiparametric magnetic resonance imaging (mpMRI), directly addressing the critical need for accurate localization and staging in primary prostate cancer. In his landmark 2023 study, cited 20 times, Prette conducted a rigorous head-to-head comparison of 18F-PSMA-1007 PET/CT against mpMRI, using whole-mount histopathology as the definitive reference standard. This work provided pivotal evidence on the superior sensitivity of PSMA-PET for detecting intraprostatic lesions and extraprostatic extension, directly informing clinical decision-making and guiding targeted biopsies. Beyond this core contribution, Prette’s research has consistently pushed the boundaries of non-invasive tumor characterization, helping to reduce unnecessary biopsies and improve risk stratification. His findings are widely recognized for their methodological rigor and direct translational impact, making him a key voice in the ongoing evolution of precision imaging for prostate cancer management.
Research Focus
Key Achievements
Top Papers
- 1